Atia Vision
PrivateLast Round
Series E
Aug 2, 2022
Total Funding Raised
$75M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Atia Vision operates in Healthcare & Life Sciences and is based in Campbell, California. Its latest recorded funding round was a Series E round in August 2022.
Atia Vision is a medical device company developing modular, shape-changing intraocular lens systems designed to restore dynamic range of vision for patients with cataracts and presbyopia.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atia Vision Comparables
Compare Atia Vision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LensGen | 93% | |
| Adaptilens | 86% | |
| AkkoLens International | 83% |
For institutional investors. Book with your work email.
Atia Vision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Aug 2, 2022 | ||||
| Series D | May 2, 2019 | ||||
| Series C | Nov 9, 2018 | ||||
| Series B | May 1, 2015 |
For institutional investors. Book with your work email.
Atia Vision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rising Tide Fund | Series B |
| Shifamed | Series B, Series E, Series D |
| Cormorant Asset Management | Series E, Series D |
| ARTIS Ventures | Series B |
| The Capital Partnership | Series E, Series D, Series C |
| PA MedTech VC Fund | Series E |
| ShangBay Capital | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 762% MoM, reaching 3.2K.
- Apr 14, 2026
Attended ASCRS to report on clinical trial results.
For institutional investors. Book with your work email.
Atia Vision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Atia Vision's valuation, stock price, and market status.
Is Atia Vision a public or private company?
Atia Vision is a private company.
What is the current stock price of Atia Vision?
Atia Vision is a private company, so its shares have no public market price. Caplight tracks Atia Vision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Atia Vision worth (valuation)?
Valuation information for Atia Vision is not publicly available.
Can I buy Atia Vision stock?
Atia Vision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Atia Vision's last funding round?
Atia Vision's most recent funding round was Series E on August 2, 2022.
Who are the main investors in Atia Vision?
Key investors in Atia Vision include Shifamed, Cormorant Asset Management, The Capital Partnership, Cormorant Asset Management.
Will Atia Vision IPO soon?
No public IPO plans have been announced for Atia Vision.
How can I track Atia Vision secondary market activity?
Caplight tracks bids, offers, and trades in Atia Vision's shares on secondary markets.